Aaron Lubetsky
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project.
Journal: Gynecologic oncology
Published: April 02, 2026
Pulmonary Embolism in Cancer Patients: A Review.
Journal: The Israel Medical Association journal : IMAJ
Published: March 29, 2022
Venous Thromboembolism Among Patients With Inflammatory Bowel Diseases is Not Related to Increased Thrombophilia: A Case-Control Study.
Journal: Journal of clinical gastroenterology
Published: February 09, 2021
Emicizumab prophylaxis: Prospective longitudinal real-world follow-up and monitoring.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 08, 2021
Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real-world data.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 04, 2020
Pulmonary Endarterectomy Surgery for Chronic Thromboembolic Pulmonary Hypertension: A Small-Volume National Referral Center Experience.
Journal: The Israel Medical Association journal : IMAJ
Published: September 02, 2019
Long-term safety and efficacy of rIX-FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 28, 2019
PEDIATRIC VENOUS THROMBOEMBOLISM - A COHORT STUDY IN A TERTIARY CENTER
Journal: Harefuah
Published: March 28, 2019
A novel approach using ancillary tests to guide treatment of Glanzmann thrombasthenia patients undergoing surgical procedures.
Journal: Blood cells, molecules & diseases
Published: July 10, 2018
Superficial abdominal thrombophlebitis (Mondor's disease) presenting as loss of response to adalimumab in a Crohn's disease patient.
Journal: Journal of Crohn's & colitis
Published: April 23, 2014
Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B.
Journal: Thrombosis research
Published: March 30, 2013
Last Updated: 09/26/2026